Switch to
More onapp

How to use scorecard? Learn more

Astrazeneca Pharma India Ltd

ASTRAZEN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16,572 cr, stock is ranked 414
High RiskStock is 3.55x as volatile as Nifty
6,624.4525.95 (-0.39%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹16,572 cr, stock is ranked 414
High RiskStock is 3.55x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
202.25
PB RatioPB Ratio
23.28
Dividend YieldDiv. Yield
0.36%
Sector PESector PE
51.53
Sector PBSector PB
6.56
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.

Brands

Astrazeneca Pharma

Pharmaceutical company

Brands

Astrazeneca Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320240.830.821.031.350.090.060.100.16
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Trading Window-XBRL 
Announced OnDec 12, 2024

ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Closure of Trading Window | Download

ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Closure of Trading Window | Download

Trading Window 
Announced OnDec 12, 2024

AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Cash Dividend 
Ex. DateJul 5, 2024

Final • Div/Share: ₹ 24

See all events